| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 79 | 2019 | 1422 | 3.950 |
Why?
|
| Infection Control | 29 | 2019 | 982 | 2.240 |
Why?
|
| Quality Improvement | 20 | 2019 | 3797 | 1.870 |
Why?
|
| Hospitals, Pediatric | 31 | 2013 | 1859 | 1.450 |
Why?
|
| Staphylococcal Infections | 33 | 2019 | 1406 | 1.440 |
Why?
|
| Intensive Care Units, Neonatal | 28 | 2019 | 846 | 1.140 |
Why?
|
| Bacteremia | 19 | 2015 | 977 | 1.080 |
Why?
|
| Drug Resistance, Bacterial | 9 | 2024 | 1048 | 1.020 |
Why?
|
| Tracheotomy | 4 | 2011 | 167 | 0.990 |
Why?
|
| Quality of Health Care | 24 | 2020 | 4321 | 0.980 |
Why?
|
| Medication Errors | 11 | 2010 | 783 | 0.920 |
Why?
|
| Quality Assurance, Health Care | 14 | 2018 | 2164 | 0.910 |
Why?
|
| Latent Tuberculosis | 5 | 2024 | 224 | 0.870 |
Why?
|
| Drug Resistance, Multiple | 6 | 2012 | 255 | 0.830 |
Why?
|
| Surgical Wound Infection | 15 | 2018 | 1529 | 0.800 |
Why?
|
| Respiratory Tract Infections | 8 | 2008 | 1009 | 0.760 |
Why?
|
| Models, Organizational | 5 | 2018 | 544 | 0.760 |
Why?
|
| Health Plan Implementation | 1 | 2024 | 335 | 0.750 |
Why?
|
| Chlorhexidine | 5 | 2019 | 160 | 0.750 |
Why?
|
| Catheter-Related Infections | 8 | 2019 | 273 | 0.750 |
Why?
|
| Anti-Infective Agents, Local | 8 | 2019 | 247 | 0.720 |
Why?
|
| Medical Errors | 12 | 2012 | 1263 | 0.690 |
Why?
|
| Staphylococcus epidermidis | 15 | 2015 | 123 | 0.690 |
Why?
|
| Diffusion of Innovation | 2 | 2018 | 729 | 0.680 |
Why?
|
| Anti-Bacterial Agents | 37 | 2024 | 7402 | 0.650 |
Why?
|
| Attitude of Health Personnel | 8 | 2018 | 3879 | 0.630 |
Why?
|
| Drug Resistance, Microbial | 18 | 2008 | 825 | 0.620 |
Why?
|
| Catheters, Indwelling | 12 | 2019 | 426 | 0.610 |
Why?
|
| Parents | 11 | 2016 | 3563 | 0.600 |
Why?
|
| Hospitals | 20 | 2019 | 3877 | 0.590 |
Why?
|
| Vancomycin | 10 | 2005 | 503 | 0.590 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5332 | 0.580 |
Why?
|
| Pediatrics | 15 | 2015 | 3588 | 0.570 |
Why?
|
| Safety Management | 5 | 2015 | 760 | 0.570 |
Why?
|
| Staphylococcus aureus | 15 | 2010 | 1457 | 0.560 |
Why?
|
| Evidence-Based Practice | 3 | 2018 | 494 | 0.550 |
Why?
|
| Epidemiologic Methods | 7 | 2017 | 1335 | 0.540 |
Why?
|
| Disinfection | 6 | 2019 | 207 | 0.540 |
Why?
|
| Arthroplasty, Replacement | 2 | 2017 | 309 | 0.530 |
Why?
|
| Intensive Care, Neonatal | 4 | 2004 | 199 | 0.520 |
Why?
|
| Bacterial Infections | 14 | 2024 | 1389 | 0.510 |
Why?
|
| Polysaccharides, Bacterial | 17 | 2007 | 578 | 0.510 |
Why?
|
| Disease Outbreaks | 7 | 2012 | 1748 | 0.510 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2006 | 33 | 0.510 |
Why?
|
| Medical Audit | 6 | 2019 | 453 | 0.500 |
Why?
|
| Cooperative Behavior | 5 | 2017 | 1504 | 0.490 |
Why?
|
| Total Quality Management | 6 | 2003 | 262 | 0.470 |
Why?
|
| Gastrointestinal Diseases | 4 | 2008 | 1201 | 0.440 |
Why?
|
| Guideline Adherence | 10 | 2017 | 2218 | 0.440 |
Why?
|
| Staphylococcus | 9 | 2005 | 153 | 0.440 |
Why?
|
| Catheterization, Central Venous | 7 | 2011 | 526 | 0.430 |
Why?
|
| Cystic Fibrosis | 14 | 2008 | 1285 | 0.430 |
Why?
|
| Sepsis | 23 | 2009 | 2585 | 0.430 |
Why?
|
| Infant, Newborn | 63 | 2019 | 26180 | 0.430 |
Why?
|
| Tuberculosis | 5 | 2024 | 2015 | 0.430 |
Why?
|
| Quality Indicators, Health Care | 9 | 2019 | 1790 | 0.430 |
Why?
|
| Hospitalists | 5 | 2007 | 294 | 0.430 |
Why?
|
| Personnel, Hospital | 5 | 2015 | 285 | 0.430 |
Why?
|
| Baths | 2 | 2013 | 53 | 0.420 |
Why?
|
| Intensive Care Units | 12 | 2019 | 3742 | 0.410 |
Why?
|
| Hospitals, Teaching | 8 | 2010 | 1155 | 0.400 |
Why?
|
| Bacteriological Techniques | 8 | 2008 | 275 | 0.400 |
Why?
|
| Humans | 272 | 2024 | 760617 | 0.400 |
Why?
|
| Workload | 1 | 2018 | 844 | 0.390 |
Why?
|
| Disinfectants | 1 | 2013 | 129 | 0.380 |
Why?
|
| Child, Preschool | 60 | 2022 | 42188 | 0.380 |
Why?
|
| Acetylglucosamine | 8 | 2010 | 189 | 0.370 |
Why?
|
| Causality | 1 | 2017 | 1240 | 0.370 |
Why?
|
| Harm Reduction | 1 | 2012 | 144 | 0.360 |
Why?
|
| Hospital Mortality | 10 | 2016 | 5293 | 0.360 |
Why?
|
| Organizational Innovation | 5 | 2018 | 537 | 0.360 |
Why?
|
| Length of Stay | 15 | 2023 | 6418 | 0.350 |
Why?
|
| United States | 65 | 2023 | 72272 | 0.340 |
Why?
|
| Antibodies, Bacterial | 10 | 2010 | 1463 | 0.340 |
Why?
|
| Vancomycin Resistance | 5 | 2011 | 125 | 0.340 |
Why?
|
| Pseudomonas Infections | 5 | 2008 | 621 | 0.340 |
Why?
|
| Child | 82 | 2024 | 80079 | 0.340 |
Why?
|
| Infant | 53 | 2018 | 36152 | 0.330 |
Why?
|
| Blood | 4 | 2008 | 596 | 0.330 |
Why?
|
| Sick Role | 1 | 2009 | 229 | 0.320 |
Why?
|
| Reimbursement, Incentive | 5 | 2019 | 542 | 0.320 |
Why?
|
| Salmonella paratyphi A | 1 | 2008 | 47 | 0.320 |
Why?
|
| Paratyphoid Fever | 1 | 2008 | 34 | 0.310 |
Why?
|
| Infant, Newborn, Diseases | 9 | 2004 | 589 | 0.310 |
Why?
|
| Streptococcal Infections | 7 | 2008 | 617 | 0.310 |
Why?
|
| Pharmacists | 2 | 2008 | 258 | 0.310 |
Why?
|
| Methicillin Resistance | 4 | 2007 | 198 | 0.300 |
Why?
|
| Pseudomonas aeruginosa | 8 | 2008 | 1272 | 0.300 |
Why?
|
| Culture Media | 4 | 2008 | 895 | 0.290 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 3 | 2008 | 494 | 0.290 |
Why?
|
| Absenteeism | 2 | 2008 | 247 | 0.290 |
Why?
|
| Conscious Sedation | 2 | 2009 | 531 | 0.290 |
Why?
|
| Program Evaluation | 7 | 2018 | 2486 | 0.290 |
Why?
|
| Program Development | 7 | 2018 | 1293 | 0.280 |
Why?
|
| Salmonella typhi | 1 | 2008 | 198 | 0.280 |
Why?
|
| Health Care Surveys | 12 | 2018 | 2423 | 0.280 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 305 | 0.280 |
Why?
|
| Typhoid Fever | 1 | 2008 | 194 | 0.280 |
Why?
|
| Bacterial Adhesion | 9 | 2004 | 306 | 0.280 |
Why?
|
| Urinary Tract Infections | 8 | 2019 | 802 | 0.270 |
Why?
|
| Health Care Reform | 3 | 2017 | 1247 | 0.270 |
Why?
|
| Research Support as Topic | 1 | 2011 | 697 | 0.270 |
Why?
|
| Mediastinitis | 2 | 2018 | 49 | 0.270 |
Why?
|
| Computers | 2 | 2006 | 591 | 0.260 |
Why?
|
| Medical Informatics Applications | 2 | 2005 | 179 | 0.260 |
Why?
|
| Hospital Administration | 3 | 2002 | 353 | 0.260 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 928 | 0.260 |
Why?
|
| Emergency Service, Hospital | 11 | 2009 | 7871 | 0.260 |
Why?
|
| Alcohols | 2 | 2005 | 94 | 0.260 |
Why?
|
| Gram-Positive Bacterial Infections | 7 | 2011 | 342 | 0.260 |
Why?
|
| Critical Illness | 5 | 2014 | 2709 | 0.250 |
Why?
|
| Health Services Research | 5 | 2016 | 1808 | 0.250 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1400 | 0.250 |
Why?
|
| Ketolides | 1 | 2005 | 12 | 0.250 |
Why?
|
| Lyme Disease | 3 | 2016 | 631 | 0.250 |
Why?
|
| Comparative Effectiveness Research | 1 | 2011 | 708 | 0.250 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2007 | 187 | 0.250 |
Why?
|
| Burkholderia Infections | 1 | 2005 | 41 | 0.250 |
Why?
|
| Patient Readmission | 4 | 2013 | 3269 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 11 | 2015 | 7389 | 0.250 |
Why?
|
| Common Cold | 2 | 2003 | 63 | 0.250 |
Why?
|
| Professional Role | 1 | 2008 | 313 | 0.250 |
Why?
|
| Medical History Taking | 3 | 2005 | 773 | 0.250 |
Why?
|
| Fimbriae, Bacterial | 4 | 1989 | 138 | 0.250 |
Why?
|
| Otitis Externa | 1 | 2004 | 17 | 0.250 |
Why?
|
| Infant Mortality | 6 | 2018 | 751 | 0.240 |
Why?
|
| Communicable Disease Control | 5 | 2005 | 846 | 0.240 |
Why?
|
| Consultants | 1 | 2005 | 56 | 0.240 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2019 | 697 | 0.240 |
Why?
|
| Analgesia | 1 | 2009 | 461 | 0.240 |
Why?
|
| Multimedia | 1 | 2005 | 75 | 0.240 |
Why?
|
| Benchmarking | 4 | 2016 | 1045 | 0.230 |
Why?
|
| Infant, Low Birth Weight | 7 | 2006 | 869 | 0.230 |
Why?
|
| Blood Bactericidal Activity | 3 | 2000 | 124 | 0.230 |
Why?
|
| Rhinovirus | 3 | 2001 | 203 | 0.230 |
Why?
|
| Health Resources | 2 | 2011 | 933 | 0.230 |
Why?
|
| Otitis Media | 2 | 2009 | 286 | 0.230 |
Why?
|
| Insurance Claim Review | 3 | 2018 | 741 | 0.220 |
Why?
|
| Economics, Hospital | 3 | 2018 | 210 | 0.220 |
Why?
|
| Gram-Negative Bacteria | 2 | 2000 | 271 | 0.220 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2016 | 85 | 0.220 |
Why?
|
| Ambulatory Care | 5 | 2017 | 2768 | 0.220 |
Why?
|
| Clostridium Infections | 1 | 2010 | 557 | 0.220 |
Why?
|
| Case Management | 1 | 2005 | 272 | 0.220 |
Why?
|
| Coagulase | 10 | 1999 | 54 | 0.210 |
Why?
|
| Opsonin Proteins | 6 | 2010 | 144 | 0.210 |
Why?
|
| Population Surveillance | 7 | 2015 | 2595 | 0.210 |
Why?
|
| Enterococcus | 4 | 2011 | 159 | 0.210 |
Why?
|
| Health Education | 2 | 2008 | 1049 | 0.200 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2016 | 279 | 0.200 |
Why?
|
| Blood Proteins | 4 | 2002 | 1172 | 0.200 |
Why?
|
| Escherichia coli Infections | 5 | 2007 | 518 | 0.200 |
Why?
|
| Skin Care | 1 | 2002 | 56 | 0.200 |
Why?
|
| Patient Discharge | 3 | 2013 | 3442 | 0.200 |
Why?
|
| Health Personnel | 4 | 2011 | 3333 | 0.200 |
Why?
|
| Ethanol | 2 | 2005 | 1320 | 0.200 |
Why?
|
| Health Maintenance Organizations | 3 | 2007 | 658 | 0.190 |
Why?
|
| Pneumonia, Bacterial | 1 | 2004 | 315 | 0.190 |
Why?
|
| Picornaviridae Infections | 2 | 2001 | 95 | 0.190 |
Why?
|
| Safety | 4 | 2010 | 1149 | 0.190 |
Why?
|
| Urinary Catheterization | 2 | 2019 | 193 | 0.190 |
Why?
|
| Hospital-Physician Relations | 1 | 2001 | 17 | 0.190 |
Why?
|
| Malpractice | 2 | 2017 | 556 | 0.190 |
Why?
|
| Organizational Culture | 3 | 2011 | 509 | 0.190 |
Why?
|
| Adolescent | 45 | 2024 | 88234 | 0.190 |
Why?
|
| Delphi Technique | 3 | 2018 | 846 | 0.190 |
Why?
|
| Enterococcus faecalis | 5 | 2000 | 245 | 0.180 |
Why?
|
| Hospital Information Systems | 3 | 2011 | 394 | 0.180 |
Why?
|
| Respirovirus Infections | 3 | 1992 | 51 | 0.180 |
Why?
|
| Developing Countries | 4 | 2005 | 2867 | 0.180 |
Why?
|
| Pharyngitis | 3 | 2008 | 220 | 0.180 |
Why?
|
| Risk Management | 4 | 2017 | 557 | 0.180 |
Why?
|
| Escherichia coli | 11 | 2007 | 4209 | 0.180 |
Why?
|
| Research | 4 | 2017 | 1977 | 0.180 |
Why?
|
| Guidelines as Topic | 5 | 2014 | 1386 | 0.170 |
Why?
|
| Gloves, Surgical | 2 | 1991 | 24 | 0.170 |
Why?
|
| Povidone-Iodine | 2 | 2001 | 55 | 0.170 |
Why?
|
| Equipment Contamination | 8 | 2001 | 182 | 0.170 |
Why?
|
| Interinstitutional Relations | 1 | 2001 | 236 | 0.170 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 574 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 3 | 2019 | 561 | 0.170 |
Why?
|
| Tobramycin | 4 | 1999 | 65 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2001 | 365 | 0.160 |
Why?
|
| Streptococcus pyogenes | 4 | 2008 | 292 | 0.160 |
Why?
|
| Health Care Sector | 1 | 2001 | 195 | 0.160 |
Why?
|
| Staphylococcal Vaccines | 3 | 2005 | 32 | 0.160 |
Why?
|
| Respiratory System Abnormalities | 2 | 2010 | 67 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2023 | 407 | 0.160 |
Why?
|
| Health Services | 2 | 2008 | 751 | 0.160 |
Why?
|
| Mupirocin | 1 | 2019 | 55 | 0.160 |
Why?
|
| Drug Utilization Review | 3 | 2005 | 248 | 0.160 |
Why?
|
| Massachusetts | 15 | 2017 | 8833 | 0.160 |
Why?
|
| Severity of Illness Index | 11 | 2008 | 15828 | 0.160 |
Why?
|
| Vaccines | 3 | 2023 | 838 | 0.160 |
Why?
|
| Penicillins | 4 | 2001 | 402 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2001 | 149 | 0.150 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2001 | 254 | 0.150 |
Why?
|
| Learning | 2 | 2018 | 1740 | 0.150 |
Why?
|
| Internship and Residency | 5 | 2009 | 5878 | 0.150 |
Why?
|
| Attitude to Health | 3 | 2005 | 2024 | 0.150 |
Why?
|
| Klebsiella Infections | 2 | 2012 | 144 | 0.150 |
Why?
|
| Antisepsis | 2 | 1995 | 16 | 0.150 |
Why?
|
| Bacterial Capsules | 5 | 2000 | 243 | 0.150 |
Why?
|
| Probability | 5 | 2017 | 2475 | 0.150 |
Why?
|
| Tuberculin Test | 3 | 2022 | 206 | 0.150 |
Why?
|
| Birth Weight | 6 | 1993 | 2101 | 0.150 |
Why?
|
| Antigens, Bacterial | 6 | 2010 | 1141 | 0.150 |
Why?
|
| Hepatitis B | 2 | 2002 | 702 | 0.150 |
Why?
|
| Housing | 2 | 2000 | 669 | 0.150 |
Why?
|
| Female | 83 | 2022 | 392148 | 0.140 |
Why?
|
| Insurance Claim Reporting | 2 | 2016 | 165 | 0.140 |
Why?
|
| Patient Care Team | 4 | 2015 | 2515 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2007 | 1275 | 0.140 |
Why?
|
| Multivariate Analysis | 11 | 2013 | 12043 | 0.140 |
Why?
|
| Risk Factors | 31 | 2023 | 74115 | 0.140 |
Why?
|
| Male | 69 | 2022 | 360358 | 0.140 |
Why?
|
| Sputum | 6 | 1999 | 506 | 0.140 |
Why?
|
| Michigan | 1 | 2017 | 339 | 0.140 |
Why?
|
| Enterococcus faecium | 2 | 1999 | 101 | 0.140 |
Why?
|
| Virus Diseases | 3 | 2000 | 718 | 0.140 |
Why?
|
| Organizational Case Studies | 1 | 2017 | 301 | 0.140 |
Why?
|
| Drug Prescriptions | 6 | 2008 | 1669 | 0.130 |
Why?
|
| Hospital Charges | 2 | 2015 | 350 | 0.130 |
Why?
|
| Catheterization | 6 | 2006 | 1428 | 0.130 |
Why?
|
| Cluster Analysis | 3 | 2017 | 2700 | 0.130 |
Why?
|
| Patient Isolation | 3 | 2011 | 100 | 0.130 |
Why?
|
| Data Collection | 5 | 2013 | 3315 | 0.130 |
Why?
|
| Ticarcillin | 3 | 1986 | 8 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10199 | 0.130 |
Why?
|
| Health Policy | 3 | 2018 | 2682 | 0.130 |
Why?
|
| Beverages | 1 | 2021 | 821 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 3 | 1999 | 436 | 0.130 |
Why?
|
| Tick-Borne Diseases | 1 | 2015 | 36 | 0.120 |
Why?
|
| Drug Utilization | 7 | 2008 | 1186 | 0.120 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2014 | 1017 | 0.120 |
Why?
|
| Haemophilus influenzae | 10 | 1985 | 178 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 3351 | 0.120 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2016 | 123 | 0.120 |
Why?
|
| Adhesins, Bacterial | 4 | 2005 | 118 | 0.120 |
Why?
|
| Drug Contamination | 4 | 1990 | 151 | 0.120 |
Why?
|
| Scalp | 2 | 1988 | 389 | 0.120 |
Why?
|
| Medicare | 6 | 2018 | 6765 | 0.120 |
Why?
|
| Endoscopes | 2 | 1992 | 168 | 0.120 |
Why?
|
| Academies and Institutes | 1 | 2017 | 318 | 0.120 |
Why?
|
| beta-Glucans | 2 | 2005 | 123 | 0.120 |
Why?
|
| Haemophilus Infections | 6 | 1985 | 94 | 0.120 |
Why?
|
| Blood-Borne Pathogens | 3 | 2011 | 52 | 0.120 |
Why?
|
| Carrier State | 7 | 2019 | 522 | 0.120 |
Why?
|
| Prospective Studies | 19 | 2013 | 54360 | 0.120 |
Why?
|
| Child Day Care Centers | 2 | 2005 | 122 | 0.120 |
Why?
|
| Asthma | 5 | 2009 | 6233 | 0.110 |
Why?
|
| Meningococcal Vaccines | 2 | 2005 | 94 | 0.110 |
Why?
|
| Adolescent Health Services | 1 | 2016 | 218 | 0.110 |
Why?
|
| Plasmodium | 1 | 2016 | 246 | 0.110 |
Why?
|
| Hepatic Encephalopathy | 1 | 1995 | 143 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2009 | 3426 | 0.110 |
Why?
|
| Physicians | 4 | 2005 | 4583 | 0.110 |
Why?
|
| Child Health Services | 3 | 2016 | 644 | 0.110 |
Why?
|
| Communicable Diseases | 3 | 2005 | 871 | 0.110 |
Why?
|
| Phagocytosis | 8 | 2007 | 1526 | 0.110 |
Why?
|
| Imipenem | 2 | 1991 | 37 | 0.110 |
Why?
|
| Fetal Blood | 1 | 2000 | 1347 | 0.110 |
Why?
|
| Herpesvirus 2, Human | 1 | 1995 | 191 | 0.110 |
Why?
|
| Critical Pathways | 2 | 2013 | 474 | 0.110 |
Why?
|
| Health Services Misuse | 1 | 2015 | 244 | 0.110 |
Why?
|
| Colony Count, Microbial | 5 | 2015 | 328 | 0.110 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2004 | 92 | 0.110 |
Why?
|
| Central Supply, Hospital | 1 | 1992 | 2 | 0.110 |
Why?
|
| Nurseries, Hospital | 3 | 1989 | 17 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 13 | 2005 | 1936 | 0.110 |
Why?
|
| Neonatology | 1 | 2015 | 140 | 0.110 |
Why?
|
| Cohort Studies | 20 | 2014 | 41457 | 0.110 |
Why?
|
| England | 2 | 2014 | 526 | 0.110 |
Why?
|
| Gentamicins | 4 | 2001 | 243 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 3 | 1992 | 348 | 0.110 |
Why?
|
| Medical Order Entry Systems | 2 | 2008 | 521 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 345 | 0.110 |
Why?
|
| Lung Diseases | 4 | 2009 | 1909 | 0.110 |
Why?
|
| Penicillin G | 2 | 2001 | 40 | 0.100 |
Why?
|
| Azlocillin | 5 | 1999 | 19 | 0.100 |
Why?
|
| Injections, Intravenous | 4 | 2012 | 1376 | 0.100 |
Why?
|
| Time Factors | 19 | 2015 | 39913 | 0.100 |
Why?
|
| Gels | 2 | 2005 | 420 | 0.100 |
Why?
|
| Klebsiella pneumoniae | 2 | 2012 | 249 | 0.100 |
Why?
|
| Drug Resistance | 2 | 2011 | 1594 | 0.100 |
Why?
|
| Health Care Costs | 4 | 2013 | 3238 | 0.100 |
Why?
|
| Patient Admission | 3 | 2003 | 1365 | 0.100 |
Why?
|
| Utilization Review | 2 | 2009 | 382 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 610 | 0.100 |
Why?
|
| Interdepartmental Relations | 3 | 1997 | 13 | 0.100 |
Why?
|
| Georgia | 1 | 2011 | 184 | 0.100 |
Why?
|
| Bacteria | 7 | 2009 | 2192 | 0.100 |
Why?
|
| Hygiene | 3 | 2019 | 94 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 1995 | 343 | 0.100 |
Why?
|
| Patient-Centered Care | 3 | 2013 | 1418 | 0.100 |
Why?
|
| Epidemiology | 2 | 1991 | 279 | 0.100 |
Why?
|
| Herpes Simplex | 1 | 1995 | 465 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 1914 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 3621 | 0.090 |
Why?
|
| Herpesvirus 3, Human | 1 | 1992 | 159 | 0.090 |
Why?
|
| Critical Care | 2 | 2019 | 2690 | 0.090 |
Why?
|
| Craniocerebral Trauma | 2 | 2009 | 490 | 0.090 |
Why?
|
| Boston | 12 | 2022 | 9313 | 0.090 |
Why?
|
| Patient Satisfaction | 4 | 2013 | 3451 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 3 | 1984 | 188 | 0.090 |
Why?
|
| Respiratory Function Tests | 7 | 2008 | 1683 | 0.090 |
Why?
|
| Iatrogenic Disease | 2 | 2005 | 538 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4341 | 0.090 |
Why?
|
| Rifampin | 5 | 1983 | 339 | 0.090 |
Why?
|
| Protective Clothing | 1 | 1991 | 103 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2018 | 1393 | 0.090 |
Why?
|
| Cephalosporins | 2 | 2001 | 198 | 0.090 |
Why?
|
| Virulence | 6 | 2005 | 1299 | 0.090 |
Why?
|
| Hospitalization | 6 | 2023 | 10704 | 0.090 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2011 | 72 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 2 | 2005 | 397 | 0.090 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2697 | 0.090 |
Why?
|
| Politics | 1 | 2017 | 813 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 1990 | 8 | 0.090 |
Why?
|
| Infusions, Parenteral | 3 | 1981 | 397 | 0.090 |
Why?
|
| Campylobacter | 1 | 1990 | 57 | 0.090 |
Why?
|
| Incidence | 11 | 2015 | 21337 | 0.090 |
Why?
|
| Infant, Premature | 4 | 2010 | 2107 | 0.090 |
Why?
|
| Streptococcus pneumoniae | 3 | 2005 | 730 | 0.090 |
Why?
|
| Cephalothin | 2 | 2001 | 28 | 0.090 |
Why?
|
| Emergency Medical Services | 2 | 2014 | 1921 | 0.090 |
Why?
|
| Retrospective Studies | 17 | 2022 | 80566 | 0.090 |
Why?
|
| Information Dissemination | 2 | 2016 | 1125 | 0.080 |
Why?
|
| Illness Behavior | 1 | 2009 | 23 | 0.080 |
Why?
|
| Adult | 36 | 2019 | 220969 | 0.080 |
Why?
|
| Rabbits | 11 | 2005 | 4770 | 0.080 |
Why?
|
| Organizational Policy | 1 | 2012 | 431 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2002 | 7847 | 0.080 |
Why?
|
| Whooping Cough | 1 | 2010 | 86 | 0.080 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2002 | 141 | 0.080 |
Why?
|
| Ventilators, Mechanical | 1 | 2011 | 288 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 794 | 0.080 |
Why?
|
| Aerobiosis | 1 | 2008 | 100 | 0.080 |
Why?
|
| Anaerobiosis | 1 | 2008 | 138 | 0.080 |
Why?
|
| Coronary Artery Bypass | 2 | 2018 | 2188 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 14648 | 0.080 |
Why?
|
| Disease Notification | 1 | 2009 | 94 | 0.080 |
Why?
|
| Electronic Health Records | 3 | 2019 | 4803 | 0.080 |
Why?
|
| Immunization, Passive | 4 | 2005 | 616 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2007 | 637 | 0.080 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 990 | 0.080 |
Why?
|
| Iodophors | 1 | 1988 | 7 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 2214 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2849 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 1413 | 0.070 |
Why?
|
| Pharynx | 4 | 1988 | 432 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2010 | 1998 | 0.070 |
Why?
|
| Quality Control | 2 | 2006 | 831 | 0.070 |
Why?
|
| Time | 1 | 2009 | 545 | 0.070 |
Why?
|
| Neuromuscular Diseases | 1 | 2010 | 258 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 1998 | 314 | 0.070 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 1115 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2000 | 407 | 0.070 |
Why?
|
| Odds Ratio | 6 | 2016 | 9643 | 0.070 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 2315 | 0.070 |
Why?
|
| Patient Care Management | 1 | 2010 | 302 | 0.070 |
Why?
|
| Animals, Newborn | 5 | 2015 | 2668 | 0.070 |
Why?
|
| Malaria | 1 | 2016 | 1226 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 3 | 1992 | 1703 | 0.070 |
Why?
|
| Patient Participation | 1 | 2016 | 1443 | 0.070 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 4 | 2005 | 55 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2009 | 9311 | 0.070 |
Why?
|
| Public Policy | 1 | 2011 | 557 | 0.070 |
Why?
|
| DNA, Bacterial | 4 | 2004 | 1471 | 0.070 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 39063 | 0.070 |
Why?
|
| Streptococcus | 2 | 2002 | 197 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2012 | 5239 | 0.070 |
Why?
|
| Penicillin Resistance | 6 | 2001 | 74 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2007 | 158 | 0.070 |
Why?
|
| Public Health Informatics | 2 | 2005 | 109 | 0.070 |
Why?
|
| Streptococcus agalactiae | 3 | 1988 | 337 | 0.070 |
Why?
|
| Ampicillin | 4 | 2001 | 136 | 0.070 |
Why?
|
| Air Microbiology | 2 | 1992 | 95 | 0.070 |
Why?
|
| Acute Disease | 4 | 2023 | 7237 | 0.060 |
Why?
|
| Focus Groups | 1 | 2011 | 1409 | 0.060 |
Why?
|
| Biofilms | 3 | 2007 | 626 | 0.060 |
Why?
|
| Insurance, Health | 4 | 2016 | 2495 | 0.060 |
Why?
|
| Pseudomonas | 1 | 1986 | 124 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2004 | 1835 | 0.060 |
Why?
|
| Child, Hospitalized | 1 | 2007 | 182 | 0.060 |
Why?
|
| Data Mining | 1 | 2011 | 551 | 0.060 |
Why?
|
| Thienamycins | 1 | 1985 | 29 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2009 | 544 | 0.060 |
Why?
|
| Capnography | 1 | 2006 | 91 | 0.060 |
Why?
|
| Antibody Specificity | 2 | 2005 | 1058 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 940 | 0.060 |
Why?
|
| Patient Identification Systems | 1 | 2006 | 75 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2006 | 123 | 0.060 |
Why?
|
| Iodine | 1 | 1988 | 287 | 0.060 |
Why?
|
| Nasopharynx | 2 | 2005 | 400 | 0.060 |
Why?
|
| Defensins | 2 | 2002 | 35 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2006 | 1191 | 0.060 |
Why?
|
| Information Services | 1 | 2006 | 236 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 2197 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3410 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10754 | 0.060 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2003 | 102 | 0.060 |
Why?
|
| Feces | 2 | 1990 | 1490 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1528 | 0.060 |
Why?
|
| Mannose | 1 | 1985 | 121 | 0.060 |
Why?
|
| Perception | 1 | 2011 | 1198 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2016 | 2630 | 0.060 |
Why?
|
| Respiratory Syncytial Viruses | 3 | 1992 | 168 | 0.060 |
Why?
|
| Emergency Treatment | 1 | 2008 | 495 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2008 | 495 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2174 | 0.060 |
Why?
|
| Teicoplanin | 1 | 2004 | 27 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2009 | 724 | 0.060 |
Why?
|
| Survival Rate | 3 | 2009 | 12719 | 0.060 |
Why?
|
| Microbiological Techniques | 1 | 2005 | 97 | 0.060 |
Why?
|
| Students | 1 | 2014 | 1733 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2871 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2002 | 352 | 0.060 |
Why?
|
| Nervous System Diseases | 3 | 2016 | 1662 | 0.060 |
Why?
|
| Nurses | 3 | 2005 | 2477 | 0.060 |
Why?
|
| Nursing Care | 1 | 2004 | 65 | 0.060 |
Why?
|
| Video Games | 1 | 2006 | 197 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2011 | 732 | 0.060 |
Why?
|
| Patient Care | 1 | 2009 | 621 | 0.060 |
Why?
|
| Family Practice | 2 | 2005 | 507 | 0.060 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2007 | 477 | 0.060 |
Why?
|
| Television | 1 | 2006 | 407 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 615 | 0.060 |
Why?
|
| Blood Specimen Collection | 2 | 2003 | 238 | 0.060 |
Why?
|
| Cyclopropanes | 1 | 1985 | 432 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 983 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2629 | 0.050 |
Why?
|
| Infant Care | 1 | 2005 | 180 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2006 | 385 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 710 | 0.050 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 26049 | 0.050 |
Why?
|
| Hospital Communication Systems | 1 | 2003 | 48 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2015 | 2053 | 0.050 |
Why?
|
| Immunization | 3 | 1993 | 1217 | 0.050 |
Why?
|
| Gastroenteritis | 3 | 1997 | 236 | 0.050 |
Why?
|
| Cephamycins | 1 | 1982 | 6 | 0.050 |
Why?
|
| Drug Therapy | 2 | 2004 | 503 | 0.050 |
Why?
|
| Bacterial Vaccines | 2 | 2000 | 399 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2001 | 1396 | 0.050 |
Why?
|
| Pneumococcal Infections | 2 | 2005 | 501 | 0.050 |
Why?
|
| Epitopes | 2 | 2006 | 2501 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2012 | 3045 | 0.050 |
Why?
|
| Decision Making | 3 | 2005 | 3918 | 0.050 |
Why?
|
| Gram-Positive Cocci | 1 | 2001 | 8 | 0.050 |
Why?
|
| Risk Adjustment | 2 | 2010 | 599 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1999 | 3800 | 0.050 |
Why?
|
| HIV | 1 | 1989 | 1579 | 0.050 |
Why?
|
| Age Factors | 8 | 2010 | 18381 | 0.050 |
Why?
|
| Animals | 27 | 2015 | 168201 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2003 | 585 | 0.050 |
Why?
|
| Drug Interactions | 3 | 2005 | 1415 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2003 | 171 | 0.050 |
Why?
|
| Analysis of Variance | 7 | 2005 | 6224 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 1984 | 432 | 0.050 |
Why?
|
| Qualitative Research | 3 | 2024 | 3016 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2005 | 1397 | 0.050 |
Why?
|
| Steel | 1 | 1981 | 27 | 0.050 |
Why?
|
| Primary Health Care | 2 | 2017 | 4668 | 0.050 |
Why?
|
| Culture | 1 | 2005 | 623 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 832 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2003 | 426 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 761 | 0.050 |
Why?
|
| Polysaccharides | 2 | 1985 | 1013 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2011 | 1187 | 0.050 |
Why?
|
| Dithioerythritol | 1 | 1980 | 8 | 0.050 |
Why?
|
| Child Behavior | 1 | 2006 | 848 | 0.050 |
Why?
|
| Clinical Protocols | 3 | 2002 | 1437 | 0.050 |
Why?
|
| Young Adult | 6 | 2023 | 59179 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2005 | 8618 | 0.050 |
Why?
|
| Alloys | 1 | 1981 | 110 | 0.050 |
Why?
|
| Linear Models | 4 | 2013 | 5866 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 645 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1980 | 93 | 0.040 |
Why?
|
| Latex Fixation Tests | 3 | 1992 | 29 | 0.040 |
Why?
|
| Medicaid | 6 | 2018 | 2814 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 1984 | 577 | 0.040 |
Why?
|
| Health Facility Merger | 1 | 2001 | 47 | 0.040 |
Why?
|
| Family Health | 1 | 2005 | 1253 | 0.040 |
Why?
|
| Comorbidity | 2 | 2019 | 10505 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 3 | 1999 | 1462 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 1981 | 245 | 0.040 |
Why?
|
| North Carolina | 2 | 2010 | 322 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 1167 | 0.040 |
Why?
|
| Eating | 1 | 2006 | 1535 | 0.040 |
Why?
|
| Research Design | 2 | 2011 | 6174 | 0.040 |
Why?
|
| Drug Therapy, Combination | 5 | 1999 | 6305 | 0.040 |
Why?
|
| Continuity of Patient Care | 3 | 2013 | 1066 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 2001 | 149 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 2423 | 0.040 |
Why?
|
| Clinical Competence | 3 | 2009 | 4789 | 0.040 |
Why?
|
| DNA Transposable Elements | 2 | 1994 | 754 | 0.040 |
Why?
|
| Prevalence | 3 | 2023 | 15689 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 3074 | 0.040 |
Why?
|
| Arthritis, Infectious | 1 | 2003 | 347 | 0.040 |
Why?
|
| Aerosols | 2 | 2000 | 635 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2008 | 1935 | 0.040 |
Why?
|
| Bandages | 1 | 2001 | 269 | 0.040 |
Why?
|
| Random Allocation | 4 | 1988 | 2392 | 0.040 |
Why?
|
| Chickenpox | 1 | 1980 | 96 | 0.040 |
Why?
|
| Clinical Trials as Topic | 6 | 2005 | 7995 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 934 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2756 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 20074 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 1999 | 195 | 0.040 |
Why?
|
| Bronchiolitis | 1 | 2005 | 485 | 0.040 |
Why?
|
| Uncertainty | 1 | 2004 | 752 | 0.040 |
Why?
|
| Prognosis | 4 | 2014 | 29600 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 1974 | 659 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 3 | 2013 | 5491 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4488 | 0.040 |
Why?
|
| Economic Competition | 1 | 2001 | 219 | 0.040 |
Why?
|
| beta-Lactamases | 2 | 1991 | 304 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2023 | 631 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 1980 | 172 | 0.040 |
Why?
|
| Communication | 3 | 2015 | 3849 | 0.040 |
Why?
|
| Neutrophils | 2 | 2002 | 3763 | 0.040 |
Why?
|
| Mycoses | 2 | 1989 | 386 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 1982 | 1605 | 0.040 |
Why?
|
| Sisomicin | 1 | 1977 | 5 | 0.040 |
Why?
|
| Sterilization | 4 | 1992 | 132 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2004 | 1131 | 0.040 |
Why?
|
| Needles | 1 | 1981 | 450 | 0.040 |
Why?
|
| Middle Aged | 15 | 2019 | 220584 | 0.040 |
Why?
|
| Disclosure | 1 | 2003 | 747 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 1998 | 166 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2002 | 1257 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2019 | 476 | 0.040 |
Why?
|
| Health Occupations | 2 | 1989 | 223 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 9172 | 0.030 |
Why?
|
| Hip Joint | 1 | 2003 | 1014 | 0.030 |
Why?
|
| Evidence-Based Medicine | 3 | 2003 | 3680 | 0.030 |
Why?
|
| Fever | 3 | 2000 | 1618 | 0.030 |
Why?
|
| Mothers | 2 | 2005 | 2194 | 0.030 |
Why?
|
| Endophthalmitis | 1 | 1999 | 260 | 0.030 |
Why?
|
| HIV Infections | 1 | 2002 | 17337 | 0.030 |
Why?
|
| Philippines | 2 | 2009 | 90 | 0.030 |
Why?
|
| Robotics | 1 | 2002 | 816 | 0.030 |
Why?
|
| Internet | 2 | 2006 | 3090 | 0.030 |
Why?
|
| Mice | 12 | 2015 | 81368 | 0.030 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 1998 | 250 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Health Facilities | 1 | 2020 | 578 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 1924 | 0.030 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1995 | 96 | 0.030 |
Why?
|
| Heart Valves | 1 | 1977 | 284 | 0.030 |
Why?
|
| Cross Reactions | 2 | 1989 | 816 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 3842 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 101 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2012 | 15612 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 2409 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4845 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 716 | 0.030 |
Why?
|
| Russia | 2 | 2007 | 382 | 0.030 |
Why?
|
| State Government | 1 | 2017 | 384 | 0.030 |
Why?
|
| Predictive Value of Tests | 4 | 2008 | 15251 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 2690 | 0.030 |
Why?
|
| Health Status | 1 | 2007 | 4075 | 0.030 |
Why?
|
| Inpatients | 2 | 2007 | 2544 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 5061 | 0.030 |
Why?
|
| Teichoic Acids | 4 | 2000 | 70 | 0.030 |
Why?
|
| Vaccines, Conjugate | 2 | 2005 | 328 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3206 | 0.030 |
Why?
|
| Developed Countries | 1 | 1997 | 450 | 0.030 |
Why?
|
| Health Priorities | 1 | 1997 | 375 | 0.030 |
Why?
|
| Plasmids | 4 | 1993 | 2265 | 0.030 |
Why?
|
| Oropharynx | 3 | 1983 | 138 | 0.030 |
Why?
|
| Trimethoprim | 2 | 1983 | 78 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2015 | 183 | 0.030 |
Why?
|
| Management Quality Circles | 1 | 1993 | 19 | 0.030 |
Why?
|
| Registries | 1 | 2010 | 8207 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 285 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6520 | 0.030 |
Why?
|
| Prejudice | 1 | 1997 | 571 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4671 | 0.030 |
Why?
|
| Prosthesis-Related Infections | 1 | 1999 | 487 | 0.030 |
Why?
|
| Spleen | 2 | 2015 | 2286 | 0.030 |
Why?
|
| Hospitals, Urban | 2 | 2007 | 500 | 0.030 |
Why?
|
| Physician-Patient Relations | 3 | 2013 | 3239 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 802 | 0.030 |
Why?
|
| Patient Selection | 1 | 2005 | 4237 | 0.030 |
Why?
|
| Prospective Payment System | 1 | 2013 | 135 | 0.030 |
Why?
|
| Genes, Bacterial | 3 | 2004 | 1073 | 0.030 |
Why?
|
| Laboratories, Hospital | 2 | 1992 | 190 | 0.030 |
Why?
|
| Time and Motion Studies | 1 | 1993 | 143 | 0.030 |
Why?
|
| Osteitis Deformans | 1 | 1992 | 54 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 731 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
| Joint Diseases | 1 | 2016 | 459 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 602 | 0.030 |
Why?
|
| Faculty, Medical | 2 | 2009 | 1204 | 0.030 |
Why?
|
| Goals | 1 | 2017 | 708 | 0.020 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 18221 | 0.020 |
Why?
|
| Judgment | 1 | 1994 | 272 | 0.020 |
Why?
|
| Risk Assessment | 6 | 2013 | 23972 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 12966 | 0.020 |
Why?
|
| Poverty | 3 | 2001 | 2692 | 0.020 |
Why?
|
| Immune Sera | 2 | 1999 | 605 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1301 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2924 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2016 | 787 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 9712 | 0.020 |
Why?
|
| Medication Systems, Hospital | 2 | 2003 | 154 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2088 | 0.020 |
Why?
|
| Surgical Attire | 1 | 2011 | 5 | 0.020 |
Why?
|
| Referral and Consultation | 3 | 2013 | 3599 | 0.020 |
Why?
|
| Logistic Models | 3 | 1997 | 13245 | 0.020 |
Why?
|
| Rotavirus Infections | 1 | 1992 | 84 | 0.020 |
Why?
|
| Gloves, Protective | 1 | 2011 | 23 | 0.020 |
Why?
|
| Spinal Dysraphism | 1 | 1993 | 178 | 0.020 |
Why?
|
| Policy Making | 1 | 2015 | 541 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 3194 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 2003 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 1992 | 290 | 0.020 |
Why?
|
| Forms and Records Control | 2 | 2005 | 158 | 0.020 |
Why?
|
| Environmental Exposure | 2 | 2000 | 4483 | 0.020 |
Why?
|
| Liver | 3 | 2015 | 7512 | 0.020 |
Why?
|
| Treatment Outcome | 7 | 2014 | 64568 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1993 | 20556 | 0.020 |
Why?
|
| Asepsis | 1 | 1990 | 5 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1992 | 239 | 0.020 |
Why?
|
| Problem Solving | 1 | 1993 | 444 | 0.020 |
Why?
|
| Campylobacter Infections | 1 | 1990 | 31 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 695 | 0.020 |
Why?
|
| Chloramphenicol | 2 | 1981 | 67 | 0.020 |
Why?
|
| Staff Development | 1 | 1992 | 227 | 0.020 |
Why?
|
| Cell Separation | 2 | 1999 | 1718 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1998 | 1490 | 0.020 |
Why?
|
| Endocarditis | 1 | 1994 | 348 | 0.020 |
Why?
|
| False Positive Reactions | 2 | 1991 | 957 | 0.020 |
Why?
|
| Double-Blind Method | 5 | 2006 | 12334 | 0.020 |
Why?
|
| Animals, Suckling | 1 | 1989 | 69 | 0.020 |
Why?
|
| Radiology Department, Hospital | 1 | 1993 | 406 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2682 | 0.020 |
Why?
|
| Surgery Department, Hospital | 1 | 1990 | 176 | 0.020 |
Why?
|
| Fatigue | 1 | 2016 | 1550 | 0.020 |
Why?
|
| Aged | 8 | 2019 | 169042 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2006 | 1779 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2000 | 1518 | 0.020 |
Why?
|
| Life Style | 1 | 2021 | 3904 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 541 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 992 | 0.020 |
Why?
|
| Risk | 5 | 1998 | 9604 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 575 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 11669 | 0.020 |
Why?
|
| Workflow | 1 | 2013 | 849 | 0.020 |
Why?
|
| Accreditation | 1 | 1992 | 473 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2007 | 2661 | 0.020 |
Why?
|
| Kinetics | 4 | 1985 | 6370 | 0.020 |
Why?
|
| Environmental Microbiology | 1 | 1988 | 47 | 0.020 |
Why?
|
| Reference Values | 2 | 2008 | 4919 | 0.020 |
Why?
|
| Blood Cells | 1 | 1990 | 305 | 0.020 |
Why?
|
| Government Agencies | 1 | 1988 | 160 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1992 | 601 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 12943 | 0.020 |
Why?
|
| Methods | 2 | 1981 | 1065 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 1964 | 0.020 |
Why?
|
| Species Specificity | 2 | 1984 | 2411 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 1602 | 0.020 |
Why?
|
| Leadership | 1 | 1997 | 1385 | 0.020 |
Why?
|
| Child Welfare | 1 | 2011 | 521 | 0.020 |
Why?
|
| Latin America | 1 | 1988 | 407 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22148 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 365 | 0.020 |
Why?
|
| Medical Records | 2 | 2006 | 1407 | 0.020 |
Why?
|
| Meningomyelocele | 1 | 1988 | 171 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 1992 | 666 | 0.020 |
Why?
|
| Klebsiella | 2 | 1978 | 49 | 0.020 |
Why?
|
| Milk | 1 | 1989 | 442 | 0.020 |
Why?
|
| ROC Curve | 2 | 2010 | 3575 | 0.020 |
Why?
|
| Triage | 1 | 1993 | 983 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4117 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 12447 | 0.020 |
Why?
|
| Vaccination | 3 | 2006 | 3370 | 0.020 |
Why?
|
| Cilastatin | 1 | 1985 | 12 | 0.020 |
Why?
|
| Decision Trees | 1 | 1987 | 504 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2005 | 4533 | 0.020 |
Why?
|
| Plankton | 1 | 2005 | 21 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6074 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22115 | 0.020 |
Why?
|
| Socioeconomic Factors | 4 | 2006 | 7798 | 0.020 |
Why?
|
| Agglutination Tests | 1 | 1985 | 41 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2000 | 5073 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 175 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2008 | 450 | 0.020 |
Why?
|
| Serotyping | 1 | 2005 | 325 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7583 | 0.020 |
Why?
|
| Rats | 3 | 1989 | 23717 | 0.020 |
Why?
|
| Sex Factors | 3 | 2008 | 10548 | 0.010 |
Why?
|
| Financing, Government | 1 | 1988 | 472 | 0.010 |
Why?
|
| Pneumonia | 4 | 1991 | 2143 | 0.010 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 617 | 0.010 |
Why?
|
| Empyema | 1 | 1984 | 41 | 0.010 |
Why?
|
| Palliative Care | 1 | 1999 | 3592 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 2005 | 210 | 0.010 |
Why?
|
| DNA Topoisomerase IV | 1 | 2004 | 42 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12116 | 0.010 |
Why?
|
| Teaching | 1 | 1992 | 1169 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 12933 | 0.010 |
Why?
|
| Complement C3 | 1 | 2006 | 434 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2606 | 0.010 |
Why?
|
| Meningitis, Haemophilus | 2 | 1981 | 20 | 0.010 |
Why?
|
| Greece | 1 | 1984 | 340 | 0.010 |
Why?
|
| Restaurants | 1 | 2006 | 231 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1983 | 52 | 0.010 |
Why?
|
| Phagocytes | 1 | 2005 | 295 | 0.010 |
Why?
|
| Serratia marcescens | 2 | 1990 | 46 | 0.010 |
Why?
|
| Attitude to Computers | 1 | 2004 | 195 | 0.010 |
Why?
|
| Oxacillin | 1 | 1983 | 41 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1988 | 521 | 0.010 |
Why?
|
| Schools | 1 | 1992 | 1483 | 0.010 |
Why?
|
| Health Surveys | 2 | 2006 | 4037 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3900 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1991 | 1683 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2004 | 373 | 0.010 |
Why?
|
| Solubility | 1 | 1985 | 1089 | 0.010 |
Why?
|
| Moxalactam | 1 | 1982 | 9 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1990 | 1269 | 0.010 |
Why?
|
| North America | 1 | 2006 | 1273 | 0.010 |
Why?
|
| Computer Systems | 1 | 2004 | 469 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Immunochemistry | 1 | 2002 | 116 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7960 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1985 | 2185 | 0.010 |
Why?
|
| Patient Access to Records | 1 | 2003 | 119 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1984 | 390 | 0.010 |
Why?
|
| Weight Gain | 1 | 2012 | 2350 | 0.010 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2003 | 134 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 135 | 0.010 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2001 | 41 | 0.010 |
Why?
|
| Endometritis | 1 | 2001 | 49 | 0.010 |
Why?
|
| Glucuronates | 1 | 1981 | 40 | 0.010 |
Why?
|
| Hospitals, Voluntary | 1 | 2001 | 39 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58894 | 0.010 |
Why?
|
| Electronic Mail | 1 | 2003 | 213 | 0.010 |
Why?
|
| Equipment Design | 1 | 1990 | 3501 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 1663 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2003 | 291 | 0.010 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2003 | 197 | 0.010 |
Why?
|
| Digestive System | 1 | 1982 | 244 | 0.010 |
Why?
|
| Myanmar | 1 | 2001 | 43 | 0.010 |
Why?
|
| Thiamphenicol | 1 | 1981 | 2 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1983 | 216 | 0.010 |
Why?
|
| Algorithms | 2 | 2004 | 14018 | 0.010 |
Why?
|
| Milk, Human | 1 | 2006 | 486 | 0.010 |
Why?
|
| Phlebitis | 1 | 1981 | 35 | 0.010 |
Why?
|
| Fruit | 1 | 2006 | 1157 | 0.010 |
Why?
|
| Vegetables | 1 | 2006 | 1191 | 0.010 |
Why?
|
| Ileum | 1 | 1983 | 557 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2925 | 0.010 |
Why?
|
| Pregnancy | 5 | 2001 | 29868 | 0.010 |
Why?
|
| Brain | 1 | 1988 | 27101 | 0.010 |
Why?
|
| Medically Uninsured | 2 | 1997 | 835 | 0.010 |
Why?
|
| Colombia | 1 | 2001 | 282 | 0.010 |
Why?
|
| Mouth | 1 | 1983 | 381 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 2089 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 287 | 0.010 |
Why?
|
| Air Movements | 1 | 1980 | 40 | 0.010 |
Why?
|
| Vagina | 1 | 1986 | 841 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1565 | 0.010 |
Why?
|
| Hungary | 1 | 2000 | 82 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1985 | 2495 | 0.010 |
Why?
|
| Communication Barriers | 1 | 2003 | 414 | 0.010 |
Why?
|
| Telephone | 1 | 2003 | 626 | 0.010 |
Why?
|
| Philadelphia | 1 | 2000 | 267 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14389 | 0.010 |
Why?
|
| Epithelium | 1 | 1984 | 1603 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 509 | 0.010 |
Why?
|
| Salmonella | 1 | 1980 | 125 | 0.010 |
Why?
|
| Germany | 1 | 2001 | 872 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4473 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2001 | 703 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1970 | 0.010 |
Why?
|
| Cellulitis | 1 | 1981 | 209 | 0.010 |
Why?
|
| Hospital Units | 1 | 1980 | 142 | 0.010 |
Why?
|
| Citrobacter | 1 | 1978 | 4 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2001 | 712 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 4007 | 0.010 |
Why?
|
| Enterobacter | 1 | 1978 | 44 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1988 | 2241 | 0.010 |
Why?
|
| Amino Acids | 1 | 1985 | 1717 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 317 | 0.010 |
Why?
|
| Umbilicus | 1 | 1978 | 36 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1987 | 2689 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2003 | 786 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1980 | 347 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12758 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 1981 | 527 | 0.010 |
Why?
|
| Candida albicans | 1 | 1980 | 372 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1901 | 0.010 |
Why?
|
| Enterobacteriaceae | 2 | 1981 | 161 | 0.010 |
Why?
|
| Physicians' Offices | 2 | 1988 | 60 | 0.010 |
Why?
|
| Antigens | 1 | 1982 | 1441 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1989 | 3039 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1983 | 2358 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1978 | 251 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1999 | 971 | 0.010 |
Why?
|
| Curriculum | 1 | 2009 | 3738 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4614 | 0.010 |
Why?
|
| Adolescent, Hospitalized | 1 | 1995 | 30 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1998 | 734 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2002 | 1252 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1064 | 0.010 |
Why?
|
| International Cooperation | 1 | 2001 | 1421 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12421 | 0.010 |
Why?
|
| Cromolyn Sodium | 1 | 1995 | 78 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2003 | 1086 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5863 | 0.010 |
Why?
|
| Nose | 1 | 1978 | 521 | 0.010 |
Why?
|
| India | 1 | 2001 | 2286 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11874 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 2852 | 0.010 |
Why?
|
| Kidney | 2 | 2000 | 7045 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 139 | 0.010 |
Why?
|
| Shigella | 1 | 1974 | 68 | 0.010 |
Why?
|
| Dysentery, Bacillary | 1 | 1974 | 73 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2001 | 1037 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1999 | 1550 | 0.010 |
Why?
|
| Hypotonic Solutions | 1 | 1973 | 48 | 0.010 |
Why?
|
| Hexachlorophene | 1 | 1973 | 5 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1995 | 346 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17629 | 0.010 |
Why?
|
| Periarthritis | 1 | 1992 | 4 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2003 | 1265 | 0.010 |
Why?
|
| Intestines | 1 | 1982 | 1909 | 0.010 |
Why?
|
| Public Health | 1 | 2006 | 2669 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1993 | 76 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1985 | 13441 | 0.010 |
Why?
|
| Arthritis, Gouty | 1 | 1992 | 28 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 13347 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 5780 | 0.010 |
Why?
|
| Filtration | 1 | 1973 | 228 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1983 | 3031 | 0.010 |
Why?
|
| Iowa | 1 | 1992 | 104 | 0.010 |
Why?
|
| Complement Activation | 1 | 1994 | 445 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5034 | 0.010 |
Why?
|
| Candida | 1 | 1973 | 171 | 0.010 |
Why?
|
| Ulna | 1 | 1992 | 134 | 0.010 |
Why?
|
| Maryland | 1 | 1992 | 277 | 0.010 |
Why?
|
| Obstetrics | 1 | 1998 | 666 | 0.010 |
Why?
|
| Indonesia | 1 | 1991 | 128 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1994 | 656 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13495 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 206 | 0.010 |
Why?
|
| Hospital Bed Capacity | 1 | 1992 | 206 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1998 | 1140 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1991 | 116 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 2371 | 0.010 |
Why?
|
| Micrococcus | 1 | 1990 | 13 | 0.010 |
Why?
|
| Software | 1 | 2004 | 4431 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1978 | 1028 | 0.010 |
Why?
|
| Proteins | 2 | 1999 | 6030 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1990 | 158 | 0.010 |
Why?
|
| Steroids | 1 | 1995 | 929 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1623 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23416 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1990 | 169 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1984 | 18937 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 436 | 0.000 |
Why?
|
| Silicone Elastomers | 1 | 1988 | 78 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1999 | 2090 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 212 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1988 | 303 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4172 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9586 | 0.000 |
Why?
|
| Iothalamic Acid | 1 | 1985 | 17 | 0.000 |
Why?
|
| Educational Status | 1 | 1993 | 2509 | 0.000 |
Why?
|
| Albumins | 1 | 1988 | 575 | 0.000 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1995 | 1810 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1992 | 1063 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 2561 | 0.000 |
Why?
|
| Income | 1 | 1993 | 1870 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 4611 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1988 | 1755 | 0.000 |
Why?
|
| Lung | 1 | 1983 | 9998 | 0.000 |
Why?
|
| Glucose | 1 | 1995 | 4345 | 0.000 |
Why?
|
| Endoscopy | 1 | 1992 | 1851 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 6961 | 0.000 |
Why?
|
| Laryngitis | 1 | 1981 | 27 | 0.000 |
Why?
|
| Chewing Gum | 1 | 1981 | 40 | 0.000 |
Why?
|
| Hydrocephalus | 1 | 1988 | 764 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1981 | 221 | 0.000 |
Why?
|
| Epiglottis | 1 | 1981 | 81 | 0.000 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1981 | 90 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2954 | 0.000 |
Why?
|
| Creatinine | 1 | 1985 | 1896 | 0.000 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 293 | 0.000 |
Why?
|
| Acetyltransferases | 1 | 1981 | 231 | 0.000 |
Why?
|
| Lipids | 1 | 1990 | 3332 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1981 | 712 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1990 | 2478 | 0.000 |
Why?
|
| Drainage | 1 | 1984 | 1156 | 0.000 |
Why?
|
| Thoracic Surgery | 1 | 1984 | 722 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1984 | 1302 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1985 | 2178 | 0.000 |
Why?
|
| Syringes | 1 | 1976 | 58 | 0.000 |
Why?
|
| Placebos | 1 | 1981 | 1667 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 16571 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1976 | 276 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1990 | 6390 | 0.000 |
Why?
|
| Water Pollution | 1 | 1974 | 31 | 0.000 |
Why?
|
| Waste Disposal, Fluid | 1 | 1974 | 33 | 0.000 |
Why?
|
| Arizona | 1 | 1974 | 107 | 0.000 |
Why?
|
| DNA | 1 | 1988 | 7196 | 0.000 |
Why?
|
| Food Handling | 1 | 1974 | 154 | 0.000 |
Why?
|
| Water Microbiology | 1 | 1974 | 113 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1983 | 2688 | 0.000 |
Why?
|
| Water Supply | 1 | 1974 | 204 | 0.000 |
Why?
|
| Food Contamination | 1 | 1974 | 191 | 0.000 |
Why?
|
| Pedigree | 1 | 1981 | 4539 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1981 | 3150 | 0.000 |
Why?
|
| Seasons | 1 | 1974 | 1518 | 0.000 |
Why?
|
| Sports | 1 | 1974 | 705 | 0.000 |
Why?
|
| Mutation | 1 | 1993 | 30016 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1984 | 14591 | 0.000 |
Why?
|